Bulletin 2009/07 - European Patent Office
13.12.2012 • Views
Share Embed Flag

Bulletin 2009/07 - European Patent Office

Bulletin 2009/07 - European Patent Office

Bulletin 2009/07 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

(A61K) I.1(1)<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) EP 20<strong>07</strong>/053809 18.04.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/118901 20<strong>07</strong>/43 25.10.20<strong>07</strong><br />

(88) 29.11.20<strong>07</strong><br />

(30) 18.04.2006 IE 20060293<br />

(54) • TRACHEAL-CYTOTOXIN (TCT) UND VER-<br />

WANDTE VERBINDUNGEN ZUR UNTER-<br />

DRÜCKUNG VON IMMUNANTWORTEN<br />

• TRACHEAL CYTOTOXIN (TCT) AND<br />

RELATED COMPOUNDS FOR SUPPRES-<br />

SING IMMUNE RESPONSES<br />

• PROCEDES ET COMPOSITIONS PERMET-<br />

TANT DE MODULER UNE REPONSE<br />

IMMUNITAIRE<br />

(71) The Provost, Fellows and Scholars of the<br />

College of the Holy and Undivided Trinity of<br />

Queen Elizabeth near Dublin, College Green,<br />

Dublin 2, IE<br />

(72) MILLS, Kingston, Dublin, DUBLIN 2, IE<br />

LAVELLE, Ed, Dublin, DUBLIN 2, IE<br />

HIGGINS, Sarah, Dublin, DUBLIN 2, IE<br />

(74) Stark, Gordon Drummond, et al, Murgitroyd<br />

& Company Unit 1, Block 8 Blanchardstown<br />

Corporate Park Blanchardstown, Dublin 15,<br />

IE<br />

A61K 38/04 → (51) C<strong>07</strong>K 14/47<br />

A61K 38/06 → (51) C<strong>07</strong>K 5/08<br />

(51) A61K 38/08 (11) 2 021 014 A1*<br />

A61K 38/26<br />

(25) En (26) En<br />

(21) 06839759.5 (22) 08.11.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 2006/060644 08.11.2006<br />

(87) WO 20<strong>07</strong>/139589 20<strong>07</strong>/49 06.12.20<strong>07</strong><br />

(30) 26.05.2006 US 809134 P<br />

(54) • GLP-1-REZEPTOR-MODULATOREN MIT<br />

VERZÖGERTER FREISETZUNG<br />

• SUSTAINED RELEASE GLP-1 RECEPTOR<br />

MODULATORS<br />

• MODULATEURS DES RÉCEPTEURS DE<br />

GLP-1 À LIBÉRATION PROLONGÉE<br />

(71) Bristol-Myers Squibb Company, Route 206<br />

and Province Line Road, Princeton NJ<br />

05843-4000, US<br />

(72) QIAN, Feng, New Brunswick, NJ 08903, US<br />

EWING, William R., Pennington, NJ 08534,<br />

US<br />

MAPELLI, Claudio, Princeton, NJ 08543, US<br />

RIEXINGER, Douglas James, Princeton, NJ<br />

08543, US<br />

LEE, Ving G., Princeton, NJ 08543, US<br />

SULSKY, Richard B., Pennington, New<br />

Jersey 08534, US<br />

ZHU, Yeheng, Pennington, NJ 08534, US<br />

HAQUE, Tasir Shamsul, Princeton, NJ<br />

08543, US<br />

MARTINEZ, Rogelio L., Monmouth Junction,<br />

NJ 08852, US<br />

NARINGREKAR, Vijay, New Brunswick, NJ<br />

08903, US<br />

NI, Nina, New Brunswick, NJ 08903, US<br />

BURTON, Lori, New Brunswick, NJ 08903,<br />

US<br />

(74) Reitstötter - Kinzebach, <strong>Patent</strong>anwälte<br />

Sternwartstrasse 4, 81679 München, DE<br />

(51) A61K 38/08 (11) 2 021 015 A2*<br />

C<strong>07</strong>K 7/06<br />

C<strong>07</strong>C 229/00<br />

C<strong>07</strong>C 15/00<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(25) En (26) En<br />

(21) <strong>07</strong>776457.9 (22) 30.04.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/010389 30.04.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/127457 20<strong>07</strong>/45 08.11.20<strong>07</strong><br />

(88) 03.04.2008<br />

(30) 28.04.2006 US 795960 P<br />

(54) • GHRELIN/GHRP/GHSR-ANTAGONISTEN<br />

UND IHRE VERWENDUNG<br />

• GHRELIN/GROWTH HORMONE RELEAS-<br />

ING PEPTIDE/GROWTH HORMONE<br />

SECRETATOGUE RECEPTOR ANTAGO-<br />

NISTS AND USES THEREOF<br />

• ANTAGONISTES DE RÉCEPTEUR DE<br />

SÉCRÉTAGOGUE D'HORMONE DE CROIS-<br />

SANCE/DE PEPTIDE LIBÉRANT UNE HOR-<br />

MONE DE CROISSANCE/DE GHRÉLINE ET<br />

UTILISATIONS DE CEUX-CI<br />

(71) The Administrators Of The Tulane Educational<br />

Fund, 1430 Tulane Avenue, New<br />

Orleans LA 70112, US<br />

(72) BOWERS, Cyril, Y., New Orleans, LA 70118,<br />

US<br />

TANNENBAUM, Gloria, S., Hampstead, Québec,<br />

H3X 3A5, CA<br />

COY, David, H., New Orleans, LA 70130, US<br />

HOCART, Simon, J., New Orleans, LA 70125,<br />

US<br />

(74) Brown, David Leslie, HASELTINE LAKE<br />

Redcliff Quay 120 Redcliff Street, Bristol BS1<br />

6HU, GB<br />

A61K 38/08 → (51) C<strong>07</strong>K 7/06<br />

A61K 38/10 → (51) C<strong>07</strong>K 14/47<br />

A61K 38/12 → (51) G01N 33/53<br />

A61K 38/14 → (51) A61K 38/04<br />

A61K 38/16 → (51) A61K 48/00<br />

A61K 38/16 → (51) C<strong>07</strong>K 14/16<br />

A61K 38/16 → (51) C12N 1/20<br />

A61K 38/17 → (51) C<strong>07</strong>K 14/47<br />

A61K 38/17 → (51) C12N 9/64<br />

A61K 38/17 → (51) C12N 15/13<br />

A61K 38/18 → (51) A61K 9/00<br />

A61K 38/19 → (51) C12N 15/19<br />

A61K 38/20 → (51) A61K 48/00<br />

A61K 38/26 → (51) A61K 38/08<br />

A61K 38/26 → (51) C<strong>07</strong>K 7/06<br />

(51) A61K 38/28 (11) 2 021 016 A2*<br />

(25) En (26) En<br />

(21) <strong>07</strong>761002.0 (22) 20.04.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/067<strong>07</strong>0 20.04.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/124414 20<strong>07</strong>/44 01.11.20<strong>07</strong><br />

(88) 24.12.2008<br />

(30) 21.04.2006 US 794018 P<br />

30.03.20<strong>07</strong> US 909128 P<br />

41<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>07</strong>/<strong>2009</strong>) 11.02.<strong>2009</strong><br />

(54) • CXCL13-ANTAGONISTEN UND IHRE VER-<br />

WENDUNG ZUR BEHANDLUNG VON ENT-<br />

ZÜNDUNGSERKRANKUNGEN<br />

• CXCL13 ANTAGONISTS AND THEIR USE<br />

FOR THE TREATMENT OF INFLAMMA-<br />

TORY DISEASES<br />

• ANTAGONISTES DE CXCL13 ET LEUR<br />

UTILISATION POUR LE TRAITEMENT DE<br />

MALADIES INFLAMMATOIRES<br />

(71) CENTOCOR, INC., 200 Great Valley Parkway,<br />

Mailcode RA-1-5, Malvern, PA 19355, US<br />

(72) BUGELSKI, Peter, Pottstown, PA 19464, US<br />

DAS, Anuk, Berwyn, PA 19312, US<br />

GRISWOLD, Donald E., North Wales, PA<br />

19454, US<br />

LIANG, Bailin, Gilbertsville, PA 19525, US<br />

LI, Li, Downingtown, PA 19335, US<br />

SARISKY, Robert A., Lansdale, PA 19446,<br />

US<br />

SHANG, Xiaozhou, West Chester, PA 19382,<br />

US<br />

(74) Marshall, Cameron John, Carpmaels &<br />

Ransford 43-45 Bloomsbury Square, London<br />

WC1A 2RA, GB<br />

A61K 38/28 → (51) C<strong>07</strong>K 14/62<br />

A61K 38/39 → (51) A61K 48/00<br />

A61K 38/39 → (51) C<strong>07</strong>K 14/47<br />

A61K 38/48 → (51) C12N 9/64<br />

(51) A61K 39/00 (11) 2 021 017 A2*<br />

C<strong>07</strong>K 14/47<br />

(25) En (26) En<br />

(21) <strong>07</strong>729468.4 (22) 24.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) EP 20<strong>07</strong>/055037 24.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/137986 20<strong>07</strong>/49 06.12.20<strong>07</strong><br />

(88) 31.01.2008<br />

(30) 26.05.2006 GB 0610547<br />

16.04.20<strong>07</strong> GB <strong>07</strong><strong>07</strong>3<strong>07</strong><br />

(54) • VERFAHREN<br />

• METHOD<br />

• MÉTHODE<br />

(71) GlaxoSmithKline Biologicals s.a., rue de<br />

l'Institut 89, 1330 Rixensart Brussels, BE<br />

(72) BRICHARD, Vincent, B-1330 Rixensart, BE<br />

LEHMANN, Frederic Francois Eugene, B-<br />

1330 Rixensart, BE<br />

(74) Lovatt, Victoria Jayne, et al, GlaxoSmithKline,<br />

Corporate Intellectual Property CN925.1, 980<br />

Great West Road, Brentford, Middlesex TW8<br />

9GS, GB<br />

(51) A61K 39/00 (11) 2 021 018 A2*<br />

A61K 39/02 A61K 39/04<br />

A61K 39/40 A61K 39/395<br />

A61K 49/00 C12Q 1/00<br />

C12Q 1/02 C12Q 1/04<br />

G01N 33/53 C12N 1/12<br />

C12N 1/20 C12N 11/00<br />

C12N 11/14<br />

C12M 3/00<br />

C12M 1/00<br />

(25) En (26) En<br />

(21) <strong>07</strong>777167.3 (22) 18.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/011957 18.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/136781 20<strong>07</strong>/48 29.11.20<strong>07</strong><br />

(88) 04.12.2008

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!